Clinical and Resistance Pattern of Coagulase Negative Staphylococci

Shaween Omed  Faiq; Sherko Ali  Omer

doi:10.56056/amj.2023.196

Authors

Shaween Omed Faiq MBChB, KHCMS Candidate, Pathology, Clinical Microbiology. College Medicine, University of Sulaimani, Kurdistan Region, Iraq.
Sherko Ali Omer MBChB, MSc, PhD. Department of Microbiology, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.

DOI:

https://doi.org/10.56056/amj.2023.196

Keywords:

Antimicrobial resistance, Coagulase negative Staphylococci, Glycopeptides

Abstract

Background and Objectives: Coagulase-negative staphylococci are commensal bacteria inhabiting human. Isolation of these bacteria from healthcare-associated and community infections is increasingly observed with resistance response to many antibiotics. The study aimed to identify the clinical and antimicrobial resistance pattern of coagulase-negative staphylococci isolated from various healthcare-associated and community-acquired infections.

Methods: This cross-sectional study was conducted in Shar Teaching Hospital and San Clinical Laboratory for a period of one year starting from 1^st of November 2019.Isolated coagulase-negative staphylococci were collected from various hospitals and clinical laboratories. The isolate species were confirmed by several tests including VITEK^®2. VITEK^® 2 systems was also used to determine the susceptibility to different antibiotics including cefoxitin, oxacillin gentamicin, linezolid, and glycopeptide agents’ teicoplanin and vancomycin which were tested also by E-test.

Results: Coagulase-negative staphylococci were isolated from urine specimens (23%), followed by blood samples (20%), sterile body fluids (12%), and others. From one hundred isolates, the most common species of coagulase-negative staphylococci were Staphylococcus epidermidis (57%), Staphylococcus haemolyticus (24%), Staphylococcus hominis (8%), and others. The isolates showed high degree of resistance to benzyl penicillin (92%), oxacillin (85%), and cefoxitin (83%). No resistance to linezolid, tigecycline, and glycopeptides was detected.

Conclusion: Staphylococcus epidermidis and Staphylococcus haemolyticus were the main coagulase-negative staphylococci isolates from several healthcare-associated infections such as bloodstream and urinary tract infection. Most of the isolates showed resistance responses to benzyl penicillin, oxacillin, and cefoxitin, while they were susceptible to glycopeptides, linezolid, and tigecycline, but intermediate response to glycopeptide was also observed.

Downloads

Download data is not yet available.

References

Natoli S, Fontana C, Favaro M, et al. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.BMC Infect Dis. 2009; 9(1): 83.

Natsis NE, Cohen PR. Coagulase-negative staphylococcus skin and soft tissue infections. Am J Clin Dermatol. 2018; 19(5): 671-7.

Singh S, Dhawan B, Kapil A, et al. Coagulase-negative staphylococci causing blood stream infection at an Indian tertiary care hospital: prevalence, antimicrobial resistance and molecular characterisation. Indian J Med Microbiol. 2017; 34(4): 500-5.

Widerström M, Wiström J, Sjöstedt A, et al. Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis. 2012; 31(1): 7-20.

Begum ES, Anbumani N, Kalyani J, et al. Prevalence and antimicrobial susceptibility pattern of Coagulase-negative Staphylococcus , Int J Med. Public Health. 2011; 1(4): 59-62 .

Cremniter J, Slassi A, Quincampoix J-C, et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol. 2010; 48(4): 1428-31.

Asaad AM. Coagulase-negative Staphylococci clinical isolates: infectious or contaminant, that is the question. Int J Clin Med Microbiol .2016; 1(101):1- 2.

Nasaj M, Saeidi Z, Asghari B, et al. Identification of hemolysin encoding genes and their association with antimicrobial resistance pattern among clinical isolates of coagulase-negative Staphylococci. BMC Research Notes. 2020; 13(1): 68.

Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.Lancet.1997; 350(9092): 1670-3.

Ahlstrand E, Svensson K, Persson L, et al. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades. Eur J Clin Microbiol Infect Dis. 2011; 30(11): 1349-54.

Shrestha LB, Bhattarai NR, Khanal B. Antibiotic resistance and biofilm formation among coagulase-negative staphylococci isolated from clinical samples at a tertiary care hospital of eastern Nepal. Antimicrob Resist Infect Control. 2017; 6(1): 89.

Raina D, Chandola I, Negi N, et al. Prevalence of Coagulase Negative Staphylococcus and their Antibiotic Sensitivity Pattern from Various Clinical Samples. J Pure Appl Microbiol. 2020; 14(2): 1255-62.

Tille PM. Bailey & Scott's Diagnostic Microbiology. 14th edition. Missouri: Elsevier; St. Louis .2014.

Ibrahim YM, Abu El-Wafa WM. Evaluation of fosfomycin combined with vancomycin against vancomycin-resistant coagulase negative staphylococci. J Chemother. 2020; 32(8): 411-9.

Szczuka E, Jab?o?ska L, Kaznowski A. Coagulase-negative staphylococci: pathogenesis, occurrence of antibiotic resistance genes and in vitro effects of antimicrobial agents on biofilm-growing bacteria. J Med Microbiol. 2016; 65(12): 1405-13.

Kloos WE, Schleifer KH. Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol. 1975; 1(1): 82-8.

Khosravi AD, Roointan M, Abbasi Montazeri E, et al. Application of tuf gene sequence analysis for the identification of species of coagulase-negative staphylococci in clinical samples and evaluation of their antimicrobial resistance pattern. Infect Drug Resist. 2018;11:1275-82.

Weinstien MP, Lewis JS, Bobenchick M et al. Performance Standards for Antimicrobial Susceptibility Testing. M100, 28th ed. Wayne, Clinical and Laboratory Standards Institute; 2018.

Sader HS, Pignatari AC. E-test: a novel technique for antimicrobial susceptibility testing. Sao Paulo Med J. 1994;112(4):635-8.

Cauwelier B, Gordts B, Descheemaecker P, Van Landuyt H. Evaluation of a disk diffusion method with cefoxitin (30 microg) for detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2004;23(5):389-92.

Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014; 27(4): 870-926.

Aher CS. The isolation pattern, species distribution and antibiotic susceptibility profile of coagulase negative Staphylococci: emerging opportunistic pathogens. Int J Biomed Adv Res. 2014; 5(01): 23-5.

Bhatt P, Tandel K, Singh A, et al. Species distribution and antimicrobial resistance pattern of Coagulase-negative Staphylococci at a tertiary care centre. Med J Armed Forces India. 2016; 72(1): 71-4.

Usha MG, Shwetha DC, Vishwanath G. Speciation of coagulase negative Staphylococcal isolates from clinically significant specimens and their antibiogram. Indian J Pathol Microbiol. 2013; 56(3): 258-60.

Otto M. Molecular basis of Staphylococcus epidermidis infections. In Seminars in immunopathology 2012; 34(2): 201-14.

Geha DJ, Uhl JR, Gustaferro CA, et al. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. J Clin Microbiol. 1994; 32(7): 1768-72.

Khan MM, Faiz A, Ashshi AM. Clinically significant Coagulase Negative Staphylococci and their antibiotic resistance pattern in a tertiary care hospital. J Pak Med Assoc. 2014; 64(10): 1171-4.

Jorgensen JH, Crawford SA, McElmeel ML, et al. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol. 2004; 42(4): 1800-2.